SHC sunshine heart, inc.

as semi retired mentioned in another post, thought wed start a...

  1. 1,224 Posts.
    as semi retired mentioned in another post, thought wed start a new thread for this subject , whether its genuine or not still doesn't stop us from discussing its effects on us and the company

    so to get the facts straight -


    -------

    http://sierraworldequityreview.blogspot.co.uk/2014/08/edwards-lifesciences-ew-to-acquire.html

    not the best source but that's how rumours spread / genuine potential news leaks

    you see it was written as a tweet. he didn't write it in big pump article. who knows ?

    ---------

    the good ?

    any potential rumours would drive the price up which would be good.
    if there are bids , and rejected it will hopefully take us to a new higher price level and we can build on that.

    the bad ?

    any premium on todays price is a low ball price. 700% premium and were at $35.

    1000% premium and were valued @ $800m .

    the company should look for at least a few billion. I would gladly sell to be honest.

    a $2b offer would take us to $100 and that should be the minimum hope if the company decides to sell out.

    looks a million miles away when were slugging it at  $5

    as they said in the cc , the company now is going through their next stage of growth . lets hope we grow price wise as well.

    so basically , any offers soon should be out of the question cuz even $800m which is a bargain for the acquirer , is a low offer due to our low price currently.

    though , any news/rumours that underline the potential of the device , I wouldn't mind at all

    brilliant scenario over the next 18 months is .

    we climb to 30 with good news and progress in the next year

    trial stops early , 200% pop , reach the $100 mark , and start a bidding war between them all.

    ..
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.